Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2002 On August 5, 2002.

Business Editors & Health/Medical Writers

BOULDER, Colo.--(BUSINESS WIRE)--July 30, 2002

Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the fourth quarter and full year of fiscal 2002 on Monday, August 5, 2002, at 4:30 p.m. eastern time and hold a conference call on Tuesday, August 6, 2002, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

CONFERENCE CALL INFORMATION
Date:             Tuesday, August 6, 2002
Time:             9:00 a.m. eastern time
Toll-Free:        [phone]
Toll:             [phone]
Web Cast:         www.arraybiopharma.com

There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free [phone], and outside the United States [phone]. The access code is 496690. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.

Array BioPharma is a drug discovery company creating small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use an integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com.